1. Cytomegalovirus infection in heart/ lung transplants: risk factors, clinical associations, response and treatment;Smyth, R.L.; Scott, J.P.; Borysiewicz, L.K.; Sharples, L.D.; Stewart, S.; Wreghitt, T.G.;Jf Infect Dis,1991
2. Cytomegalovirus infection is associated with cardiac rejection and atherosclerosis;Gratten, M.T.; Morenocabral, C.E.; Starnes, V.A.; Oyer, P.E.; Stinson, F.B.; Shumway, N.E.;JAMA,1989
3. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection;McDonald, K.; Rector, T.S.; Braulin, E.A.; Kubo, S.H.; Olivar, M.T.;Am J7 Cardiol,1989
4. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients;Duncan, SR, Paradis; IL, Yousem; SA, Similo; SL, Grgurich; WF, Williams; P.A.;Am Rev Respir Dis,1992
5. Ganciclovir prophylaxis for cytomegalovirus infection in pulmonary allograft recipients;Duncan, SR, Paradis; IL, Dauber; JH, Yousem; SA, Hardesty; RL, Griffiths; B.P.;Am Rev Respir Dis,1992